Molecular Templates, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
MTEM Company Description
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
MTEM Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view MTEM Smart Score
Score Breakdown
MTEM Company Description
Show More
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of MTEM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MTEM's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on MTEM's company Twitter account
WallStreetBets
Number of mentions of MTEM in WallStreetBets Daily Discussion
MTEM News
Recent insights relating to MTEM
CNBC Recommendations
Recent picks made for MTEM stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in MTEM
Corporate Flights
Flights by private jets registered to MTEM
Our Analysis